All Pharma News
Lilly Completes Acquisition of POINT Biopharma

Lilly Completes Acquisition of POINT Biopharma
PR NEWSWIRE
27 Dec 2023
Share Share
POINT Biopharma shareholders get long-awaited radioligand therapy data

POINT Biopharma shareholders get long-awaited radioligand therapy data
PRESS RELEASE
20 Dec 2023
Share Share
Lantheus and POINT Biopharma Announce Positive Results from SPLASH Trial

Lantheus and POINT Biopharma Announce Positive Results from SPLASH Trial
GLOBENEWSWIRE
18 Dec 2023
Share Share
Deadline for Point investors as data meets Lilly`s expectations

Deadline for Point investors as data meets Lilly`s expectations
Nick Paul Taylor FIERCE BIOTECH
18 Dec 2023
Share Share
Eli Lilly extends tender offer to buy Point Biopharma after low participation

Eli Lilly extends tender offer to buy Point Biopharma after low participation
REUTERS
17 Nov 2023
Share Share
Lilly Announces the Receipt of NRC Consent in Connection with POINT Biopharma

Lilly Announces the Receipt of NRC Consent in Connection with POINT Biopharma
PR NEWSWIRE
14 Nov 2023
Share Share
POINT Biopharma Reports Third Quarter 2023 Financial Results

POINT Biopharma Reports Third Quarter 2023 Financial Results
GLOBENEWSWIRE
13 Nov 2023
Share Share
Lilly enters radiopharmaceuticals with $1.4B Point Biopharma buy

Lilly enters radiopharmaceuticals with $1.4B Point Biopharma buy
Gabrielle Masson FIERCE BIOTECH
04 Oct 2023
Share Share
POINT Biopharma and Athebio Announce Partnership

POINT Biopharma and Athebio Announce Partnership
GLOBENEWSWIRE
18 Sep 2023
Share Share
POINT Biopharma Reports Second Quarter 2023 Financial Results

POINT Biopharma Reports Second Quarter 2023 Financial Results
GLOBENEWSWIRE
14 Aug 2023
Share Share